Brief: Pyc Therapeutics Says VP-001 Program, Got Fast Track Designation From US FDA
02/08/2023 02:27
Aug 2 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* VP-001 PROGRAM, HAS RECEIVED FAST TRACK DESIGNATION FROM
US FOOD
AND DRUG ADMINISTRATION
Source text for Eikon: ID:nASXvX629
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director